Effects of exercise on the isoelectric patterns of erythropoietin

Clinical Journal of Sport Medicine

Volumn 19, Issue 4, 2009, Pages 311-315

  Lamon, Séverine ^a   Martin, Laurent ^b   Robinson, Neil ^a   Saugy, Martial ^a   Ceaurriz, Jacques De ^b   Lasne, Françoise ^b  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b CPLD Conseil de Prévention et de Lutte Contre Le Dopage   (France)

Author keywords

Doping; Effort; Erythropoietin; Urine

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; RETINOL BINDING PROTEIN;

ARTICLE; ATHLETE; BLOOD SAMPLING; CYCLING; DOPING; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; PRIORITY JOURNAL; PROTEINURIA; TRAINING; URINALYSIS;

ADOLESCENT; ADULT; DOPING IN SPORTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; EXERCISE; FEMALE; HUMANS; ISOELECTRIC FOCUSING; MALE; SUBSTANCE ABUSE DETECTION; SWITZERLAND; YOUNG ADULT;

EID: 68449104851     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/JSM.0b013e3181a9483e     Document Type: Article

References (17)

1. Donnelly S. Why is erythropoietin made in the kidney? The kidney functions as a critmeter. Am J Kidney Dis. 2001;38:415-425.
2. Katz R, Cooper GW, Gordon AS, et al. Studies on the site of production of erythropoietin. Ann N Y Acad Sci. 1968;149:120-127.
3. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood). 2003;228:1-14.
4. Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med. 1991;229:125-130.
5. Ekblom B, Berglund B. Effect of erythropoietin administration on mammal aerobic power. Scand J Med Sci Sports. 1991;1:88-92.
6. Lasne F, Martin L, Crepin N, et al. Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal Biochem. 2002;311:119-126.
7. Catlin DH, Nissen-Lie G, Howe C, et al. WADA Technical Document TD2007EPO. 2007. http://www.wada-ama.org.
8. Lasne F, Martin L, Martin JA, et al. Isoelectric profiles of human erythropoietin are different in serum and urine. Int J Biol Macromol. 2007;41:354-357.
9. Lasne F. Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. J Immunol Methods. 2003;276:223-226.
10. Poortmans JR, Labilloy D. The influence of work intensity on postexercise proteinuria. Eur J Appl Physiol Occup Physiol. 1988;57:260-263.
11. Poortmans JR, Mathieu N, De PP. Influence of running different distances on renal glomerular and tubular impairment in humans. Eur J Appl Physiol Occup Physiol. 1996;72:522-527.
12. Poortmans JR, Brauman H, Staroukine M, et al. Indirect evidence of glomerular/tubular mixed-type postexercise proteinuria in healthy humans. Am J Physiol. 1988;254:F277-F283.
13. Just M, Habermann E. Interactions of a protease inhibitor and other peptides with isolated brush border membranes from rat renal cortex. Naunyn Schmiedebergs Arch Pharmacol. 1973;280:161-176.
14. Purtell JN, Pesce AJ, Clyne DH, et al. Isoelectric point of albumin: effect on renal handling of albumin. Kidney Int. 1979;16:366-376.
15. Ashenden M, Varlet-Marie E, Lasne F, et al. The effects of microdose recombinant human erythropoietin regimens in athletes. Haematologica. 2006;91:1143-1144.
16. Kohler M, Ayotte C, Desharnais P, et al. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. Int J Sports Med. 2008;29:1-6.
17. Reichel C, Kulovics R, Jordan V, et al. SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. Drug Test Anal. 2009;1:43-50.